Nava M.
234
Coauthors
23
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 10 |
| 2022 | 3 |
| 2023 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Obesidad | 5 |
| Bioquímica | 4 |
| Diabetes | 3 |
| Medicina interna | 3 |
| Epidemiología | 2 |
| Nutrición | 2 |
| Enfermedad cardiovascular | 2 |
| Neuropsicología | 2 |
| Fisiología | 2 |
| Infección | 2 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 20 |
| Fisiología humana | 12 |
| Farmacología y terapéutica | 8 |
| Medicina y salud | 4 |
| Salud y seguridad personal | 4 |
| Bioquímica | 1 |
| Ginecología, obstetricia, pediatría, geriatría | 1 |
| Medicina forense; incidencia de enfermedades | 1 |
| Psicología aplicada | 1 |
| Temas específicos de historia natural de los animales | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 23 |
| Google Scholar | 1 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 23 |
| González M.C. | 12 |
| Salazar-Vílchez J. | 11 |
| Ortega A. | 11 |
| D’marco L. | 11 |
| Rojas-Quintero J. | 11 |
| Rojas M. | 7 |
| Chávez-Castillo M. | 7 |
| Dávila L.C.A. | 6 |
| Martínez M.S. | 6 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusDiagnostic criteria and management of metabolic syndrome: Evolution overtime
ReviewAbstract: The beginnings of the Metabolic Syndrome (MetS) as a suspected, not yet recognized entity can be traPalabras claves:Cardiovascular disease, Diagnostic criteria, management, Metabolic syndrome, MetS updates, Type 2 DiabetesAutores:Carrasquero R., Castro A., Lameda V., Manzano A., Nava M., Rojas E.R., Suarez M.K., Valmore BermúdezFuentes:scopusDepression as an immunometabolic disorder: Exploring shared pharma-cotherapeutics with cardiovascular disease
ReviewAbstract: Modern times have seen depression and cardiovascular disease (CVD) become notorious public health coPalabras claves:Cardiovascular disease, Chronic inflammation, Depression, Insulin Resistance, metabolism, Oxidative StressAutores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusEtelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
ArticleAbstract: Introduction: secondary hyperparathyroidism (SHP) is frequent in patients with chronic kidney diseasPalabras claves:calcimimetics, Chronic kidney disease, inflammation, vitamin D analogsAutores:Checa-Ros A., Dapena F., D’marco L., Gamero D., Nava M., Salazar J., Soto C., Valmore BermúdezFuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopus